Lv1
20 积分 2024-04-29 加入
Engineering Nonpathogenic Bacteria for Synergistic Tumor-Targeted Protein Degradation and Immunotherapy by Checkpoint-Inhibiting Nanobodies
2小时前
已完结
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy
6个月前
已完结
Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer
10个月前
已完结